Form 8-K - Current report:
SEC Accession No. 0001104659-20-059038
Filing Date
2020-05-11
Accepted
2020-05-11 06:06:01
Documents
1
Period of Report
2020-05-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018938d2_8k.htm 8-K 24489
  Complete submission text file 0001104659-20-059038.txt   25768
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 20862446
SIC: 2836 Biological Products, (No Diagnostic Substances)